Submitted by Anonymous (not verified) on 18 November 2025 - 13:00
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised